Table 2. Estimated hazard of mortality due to carrying a BRCA mutation in the absence of melanoma and cancer of the breast, ovary, pancreas, and prostate¹.

Age	Female			Male
	Non-carriers	Carriers	Hazard Ratio	Non-carrier	Carrier	Hazard Ratio
<50	.038 (.034, .042)	.056 (.018, .102)	1.46 (0.50, 2.82)	.066 (.061, .071)	.079 (.026, .142)	1.19 (0.38, 2.20)
51–60	.038 (.033, .044)	.047 (.000, .129)	1.26 (0.00, 3.42)	.092 (.084, .099)	.073 (.023, .152)	0.80 (0.25, 1.68)
61–70	.091 (.082, .101)	.118 (.021, .284)	1.29 (0.22, 3.07)	.179 (.168, .192)	.312 (.166, .451)	1.74 (0.89, 2.55)
71–80	.242 (.225, .260)	.630 (.334, .857)	2.60 (1.39, 3.64)	.374 (.353, .396)	.612 (.320, .825)	1.64 (0.85, 2.25)
81–90	.593 (.556, .629)	.634 (.143, .972)	1.07 (0.25, 1.65)	.704 (.668, .741)	.844 (.418, .980)	1.20 (0.58, 1.42)
91–100	.880 (.816, .936)	.853 (.030, .975)	0.97 (0.03, 1.08)	.947 (.874, .997)	.820 (.000, .100)	0.87 (0.00, 1.08)

¹Follow-up time and deaths were censored at first report of melanoma or cancer of the breast, ovary, pancreas, or prostate.